Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TicoVac Mucosal Immune Response Study
NCT01710189Phase 4Completed
- Sponsor
- University of Surrey
- Start
- Oct 2012
- Primary completion
- Oct 2014
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by University of Surrey. Started Oct 2012; status: completed.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT01710189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01710189.